drugset / Trial / NCT01400828
Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study was to determine the efficacy and tolerability of 20 mg of Bilastine, compared to Desloratadine and placebo for the treatment of Seasonal Allergic Rhinitis.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-06
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bilastine | Small molecule | 20 mg | Oral |
| Comparator | Desloratadine | Small molecule | 5 mg | Oral |